TYRA

MKT CAP:$2B

Tyra Biosciences Inc

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$32.38+$5.59 (+20.87%)

Jul 15, 2026

52W High $39.6152W Low $10.10

Company Details

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug...

Leadership

Todd Harris Ph.D.Founder

Co-Founder, CEO, President & Director

Bhavesh Ashar M.B.A.

Chief Operating Officer

Douglas Warner M.D.

Chief Medical Officer

Daniel BensenFounder

Co-Founder & Chief Discovery Officer

Alan Fuhrman CPA

Chief Financial Officer

Julia Rueb

VP of Finance & Principal Accounting Officer

Robert L. Hudkins Ph.D.

Chief Technology Officer

Ronald V. Swanson Ph.D.

Chief Scientific Officer

Ali D. Fawaz J.D.

General Counsel & Secretary

Sarah Honig

Senior VP of Corporate Development & Strategy

IPO Date

Sep 15, 2021

Website

tyra.bio

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$131M

EPS (Diluted)

Free Cash Flow

-$102M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee